ANI Pharmaceuticals announced that it and Sofgen has received approval from the FDA of the Abbreviated New Drug Application (ANDA)...
Nimodipine is indicated for the prevention of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage.
The FDA has approved the New Drug Application (NDA) for Nymalize (nimodipine) oral solution, from Arbor Pharmaceuticals, for the improvement...
Edge Therapeutics announced updated results from its ongoing analyses of the Phase III NEWTON 2 study of EG 1962 (nimodipine...